What We're Reading: Page 35
Industry reads hand-picked by our editors
Sep 17, 2024
-
Axios
Why Trump’s drug price positions may clash with GOP’s pharma agenda
-
FirstWord Pharma
Roche details external, internal manufacturing plans to support obesity pipeline
-
The Wall Street Journal
The Battle Brewing Over Blood Tests for Cancer
Sep 16, 2024
Sep 13, 2024
Sep 12, 2024
Sep 11, 2024
-
AP News
Saxenda, a weight-loss drug, is effective for kids as young as 6, study shows
-
Fierce Biotech
Roche ramps up R&D with new high-rise labs
-
Bloomberg
GTCR Is in Advanced Talks to Buy German Drugmaker Stada
-
The New York Times
Francisco Lopera, the ‘Country Doctor’ Who Upended Our Understanding of Dementia
Sep 10, 2024
Sep 09, 2024
-
Financial Times
Pricy new cancer drugs offer patients hope but pile pressure on health budgets
-
Bloomberg
Roche Falls as Side Effects Data for Obesity Drug Raises Concern
-
NPR
Drugmakers say Ozempic, Wegovy and similar drugs are widely available. Patients disagree.
-
C&EN
Thinking on linkers for antibody-drug conjugates
Previous
